GnRH agonist Buserelin affects colony-forming efficiency of HHUA and Jurkat cells

Biochemical and Biophysical Research Communications

Volumn 289, Issue 5, 2001, Pages 1180-1187

  Enomoto, Masahiro ^a   Mori, Takao ^a   Park, Min Kyun ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autocrine; Buserelin; Cell proliferation; Colony forming efficiency; Conditioned medium; GnRH; Paracrine

Indexed keywords

BUSERELIN; GONADORELIN AGONIST;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CELL DENSITY; CELL LINE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOSE RESPONSE; ENDOMETRIUM CARCINOMA; HORMONE ACTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEASUREMENT; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL;

EID: 0035931010     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.6131     Document Type: Article

References (52)

1. Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production
2. Gonadotropin-releasing hormone as a modulator of ovarian function
3. Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: Biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulose cells
4. In situ detection of gonadotropin-releasing hormone (GnRH) receptor mRNA expression in the rat ovarian follicles
5. Gonadotropin-releasing hormone receptor mRNA expression in the ovaries of neonatal and adults rats
6. Direct inhibition of testicular function by gonadotropin-releasing hormone: Mediation by specific gonadotropin-releasing hormone receptors in interstitial cells
7. Testicular GnRH receptors - Characterization and localization on interstitial tissue
8. Characterization of a gonadotropin-releasing hormone receptor site in term placenta and chorionic villi
9. Luteinizing hormone-releasing hormone binds to enriched human placental membranes and stimulates in vitro the synthesis of bioactive human chorionic gonadotropin
10. Effect of GnRH agonisits on the thymus in female rats
11. Luteinizing hormone-releasing hormone-binding sites in the rat thymus: Characteristics and biological function
12. Luteinizing hormone-releasing hormone (LHRH) agonisit restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity
13. Tymocytes express a mRNA that is identical to hypothalamic luteinizing hormone-releasing hormone mRNA
14. Effect of LH-RH analog on cat testis and adrenal cortex function
15. Immunoreactive GnRH in hypothalamic and extrahypothalamic areas
16. Effect of luteinizing hormone-releasing hormone on rat adrenocortical cells
17. Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone
18. Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist
19. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists
20. Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone
21. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines
22. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: Possible mechanism for hormonal control of apoptotic cell death
23. Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: Role of apoptosis
24. Long-acting delivery systems for peptides: Inhibition of rat prostate tumors by controlled release of [D-Trp-6]luteinizing hormone-releasing hormone from injectable microcapsules
25. Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia
26. Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonisits on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice
27. 6-LH-RH on the survival time in patients with advanced pancreatic cancer
28. Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin
29. Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Events that accompany tumor regression
30. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice
31. Inhibition of human hepatocaricinoma cell proliferation by mammalian and fish gonadotropin-releasing hormones
32. A physiological role for the neuropeptide luteinizing hormone-releasing hormone (LHRH) during the maturation of thymus gland function
33. The gonadotropin-releasing hormone agonist leuprolide affects the thymus and other non-reproductive systems of female rats
34. Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of Interleukin-2 receptor expression
35. Effects of GnRH antagonist on lymphocyte subpopulations in primary and secondary lymphoid tissues of female mice
36. Jurkat cell proliferative activity is increased by luteinizing hormone-releasing hormone
37. Limiting dilution analysis of helper T-cell function
38. Mitochondrial peripheral-type Benzodiazepine receptor expression. Correlation with gonadotropin-releasing hormone (GnRH) agonist-induced apoptosis in the corpus luteum
39. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate)
40. Efffects of gonadotropin-releasing hormone agonist on the incidence of apoptosis in porcine and human granulosa cells
41. Gonadotropin-releasing hormone surge in pro-oestrous rats
42. Luteinizing hormone-releasing hormone and the human menstrual cycle
43. Interrelationship between changing patterns of LHRH and gonadotropins in the menstrual cycle
44. Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor γ-chain messenger ribonucleic acids that are regulated by GnRH in vitro
45. Luteinizing hormone-releasing hormone analogs: Their impact on the control of tumorigenesis
46. Blockade of central and peripheral luteinizing hormone-releasing hormone (LHRH) receptors in neonatal rats with a potent LHRH-antagonist inhibits the morphofunctional development of the thymus and maturation of the cell-mediated and humoral immune responses
47. Presence of luteinizing hormone-releasing hormone binding sites in cultured porcine lymphocytes
48. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression
49. In vivo antitumor effects of polyethylene glycol-modified recombinant human interleukin-2 on mouse uterine cervical carcinoma
50. Enhancement of apoptotic susceptibility in human endometrial epithelial cell line HHUA by transforming growth factor-beta 1
51. Enhanced Fas/CD95-mediated apoptosis by epidermal growth factor in human endometrial epithelial cells
52. Cytokine regulation of apoptotic susceptibility in a human endometrial epithelial cell line